Trial Profile
Safety and efficacy of daratumumab in patients with myeloma: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Daratumumab (Primary)
- Indications Myeloma
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017